| Specialty Retail Industry | Consumer Discretionary Sector | Dr. Satyanarayana Chava M.Sc., Ph.D. CEO | MSE Exchange | INE947Q01028 ISIN |
| IN Country | 6,167 Employees | 8 May 2026 Last Dividend | 29 Sep 2020 Last Split | - IPO Date |
Laurus Labs Limited is a distinguished entity in the pharmaceutical industry, focusing on the development, manufacture, and international sale of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). Originating in 2005 and headquartered in Hyderabad, India, the company has cemented its presence both domestically and globally. Its operations are not confined to medication development; they extend to providing comprehensive contract development and manufacturing services, alongside producing specialty ingredients for various health and wellness applications. This multifaceted approach ensures Laurus Labs Limited's significant contribution to healthcare and pharmaceuticals, emphasizing innovation, quality, and accessibility.
Laurus Labs Limited boasts a diverse portfolio of products and services designed to meet the complex needs of the healthcare and pharmaceutical industries. Here is a detailed look at their offerings: